Are you Dr. Kellum?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 68 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
961 S Gloster St
Tupelo, MS 38801Phone+1 662-844-9166- Is this information wrong?
Summary
- Dr. Andrew Kellum, MD is an oncologist in Tupelo, Mississippi. He is currently licensed to practice medicine in Mississippi, Alabama, and Oklahoma. He is affiliated with North Mississippi Medical Center - Tupelo, Magnolia Regional Health Center, and OCH Regional Medical Center.
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1982 - 1985
- University of Mississippi School of MedicineClass of 1982
Certifications & Licensure
- MS State Medical License 1983 - 2024
- AL State Medical License 1999 - 2023
- OK State Medical License 1986 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) Start of enrollment: 2015 Jun 26
- OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure Start of enrollment: 2016 Feb 12
Publications & Presentations
PubMed
- 13 citationsReal-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.Scott A. Tomlins, Daniel H. Hovelson, Jennifer Marie Suga, Daniel M. Anderson, Han A. Koh, Elizabeth Claire Dees, Brendan McNulty, Mark E. Burkard, Michael Guarino, Ja...> ;JCO Precision Oncology. 2021 Aug 19
- A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for ad...Kellum, A.,Jagiello-Gruszfeld, A.,Bondarenko, I. N.,Patwardhan, R.,Messam, C.,Mostafa Kamel, Y.> ;Curr Med Res Opin. 2010 Aug 26
Professional Memberships
- Member
Hospital Affiliations
- OCH Regional Medical CenterStarkville, Mississippi
- Magnolia Regional Health CenterCorinth, Mississippi
- North Mississippi Medical Center - TupeloTupelo, Mississippi